New eye drop cocktail aims to soothe dry eyes without preservatives

NCT ID NCT06903741

Recruiting now Symptom relief Sponsor: Laboratoires Thea Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new eye drop that combines trehalose, sodium hyaluronate, and NAAGA without preservatives. It will enroll 30 adults with dry eye disease who are either new to treatment or unhappy with their current drops. Over 6 months, researchers will track changes in symptoms and quality of life using a standard questionnaire.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: preservative-free combination of trehalose, sodium hyaluronate, and n-acetyl-aspartyl-glutamate (NAAGA) eye drops
What this could lead to: If it works, this could offer a new, well-tolerated option for people with dry eye disease who are not satisfied with current artificial tears.
What could go wrong: This is a small, early-phase study with only 30 participants and no comparison group, so results may not apply widely. The improvement may be modest or not better than existing treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE (DED) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dry eye syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRY EYE DISEASE (DED)

Contacts and locations

Locations

Group Practice Outpatient Clinic for Specialized Medical
RECRUITING

Varna, 9002, Bulgaria

More trials for these conditions

Other studies related to the condition(s) this trial covers.